Location History:
- Kulmback, DE (2013)
- Kulmbach, DE (2008 - 2019)
- Meggen, CH (2018 - 2020)
Company Filing History:
19 out of 443 
2 out of 95 
1 out of 4,942 
Years Active: 2008-2020
Title: **Birgit Bramlage: Innovator in Gene Expression Inhibition**
Introduction
Birgit Bramlage is a renowned inventor based in Kulmbach, Germany, known for her significant contributions to the field of molecular biology and pharmaceutical sciences. With an impressive portfolio of 23 patents, her work focuses on innovative methods for inhibiting gene expressions, pivotal for treating various diseases.
Latest Patents
Among her latest inventions, Birgit has developed compositions and methods for inhibiting the expression of RRM2 genes. This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the RRM2 gene, accompanied by a pharmaceutical composition that includes the dsRNA and a pharmaceutically acceptable carrier. Furthermore, it outlines methods for utilizing this composition to treat diseases linked to RRM2 gene expression.
Another notable patent focuses on inhibiting the expression of the PCSK9 gene. This invention pertains to dsRNA comprising an antisense strand that is 19-25 nucleotides in length and is substantially complementary to the PCSK9 gene. Similar to her prior work, this invention also includes a pharmaceutical composition designed to treat diseases caused by the expression of the PCSK9 gene.
Career Highlights
Throughout her career, Birgit Bramlage has been associated with reputable companies in the pharmaceutical sector, including Alnylam Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. Her expertise and innovative methods have contributed to advancing therapies that target critical pathways in disease mechanisms.
Collaborations
Birgit has collaborated with various esteemed professionals in her field, including Pamela Tan and Hans-Peter Vornlocher. These partnerships have fostered a productive environment for innovation, enabling advancements in treatments related to gene expression.
Conclusion
Birgit Bramlage continues to impact the pharmaceutical industry through her inventive work on gene expression inhibition. Her patents not only highlight her creativity and expertise but also signify the potential for breakthroughs in treating diseases effectively. The ongoing evolution of her inventions promises to shape the future of molecular therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.